Home/Filings/4/0001127602-24-029178
4//SEC Filing

Patterson Sandra 4

Accession 0001127602-24-029178

CIK 0000882095other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 7:48 PM ET

Size

8.3 KB

Accession

0001127602-24-029178

Insider Transaction Report

Form 4
Period: 2024-12-10
Patterson Sandra
SVP, Controllership
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2024-12-1090112,282 total
    Common Stock (901 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-10+90137,486 total
  • Tax Payment

    Common Stock

    2024-12-10$92.34/sh408$37,67537,078 total
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • [F2]The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001968906

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 7:48 PM ET
Size
8.3 KB